Metformin is generally safe for most people with type 2 diabetes, but around five percent of those who start metformin therapy discontinue it due to severe gastrointestinal side effects, although it’s not clear why some people experience this. Researchers believe it may relate to metformin’s effect on the gut microbiome and are currently studying whether a person’s unique microbiome can influence the tolerance of this drug.